Multi-omic, plasma biomarkers for non-small cell lung cancer demonstrate strong performance for early cancer detection - prognomiQ

NEWS & RESOURCES

Multi-omic, plasma biomarkers for non-small cell lung cancer demonstrate strong performance for early cancer detection

This presentation at the 2023 CHEST Annual Meeting demonstrated the high performance of a multi-omics statistical classifier comprised of proteins, metabolites, and RNA transcripts for the detection of early and all-stage non-small lung cancer (NSCLC) while maintaining specificity against important potential confounding factors, including smoking.

Download Presentation